nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—RXRA—prostate cancer	0.472	1	CbGaD
Acitretin—ALB—Abiraterone—prostate cancer	0.0493	0.401	CbGbCtD
Acitretin—ALB—Estrone—prostate cancer	0.0357	0.29	CbGbCtD
Acitretin—ALB—Estradiol—prostate cancer	0.0205	0.166	CbGbCtD
Acitretin—ALB—Prednisone—prostate cancer	0.0176	0.143	CbGbCtD
Acitretin—RBP1—prostate gland—prostate cancer	0.00327	0.0908	CbGeAlD
Acitretin—RARB—prostate gland—prostate cancer	0.00303	0.084	CbGeAlD
Acitretin—RXRG—prostate gland—prostate cancer	0.00296	0.0821	CbGeAlD
Acitretin—RARG—prostate gland—prostate cancer	0.00247	0.0685	CbGeAlD
Acitretin—RBP1—epithelium—prostate cancer	0.0024	0.0667	CbGeAlD
Acitretin—RARA—prostate gland—prostate cancer	0.00232	0.0644	CbGeAlD
Acitretin—RXRA—renal system—prostate cancer	0.0023	0.0638	CbGeAlD
Acitretin—RBP1—renal system—prostate cancer	0.00223	0.0619	CbGeAlD
Acitretin—RARG—urethra—prostate cancer	0.00165	0.0459	CbGeAlD
Acitretin—RARA—renal system—prostate cancer	0.00158	0.0439	CbGeAlD
Acitretin—RBP1—testis—prostate cancer	0.00144	0.04	CbGeAlD
Acitretin—RXRG—testis—prostate cancer	0.0013	0.0362	CbGeAlD
Acitretin—RXRB—testis—prostate cancer	0.00123	0.034	CbGeAlD
Acitretin—RARA—bone marrow—prostate cancer	0.0012	0.0332	CbGeAlD
Acitretin—Vitamin A—ALDH1A2—prostate cancer	0.00119	0.203	CrCbGaD
Acitretin—Tretinoin—ALDH1A2—prostate cancer	0.00115	0.196	CrCbGaD
Acitretin—RARG—testis—prostate cancer	0.00109	0.0302	CbGeAlD
Acitretin—RBP1—lymph node—prostate cancer	0.00104	0.029	CbGeAlD
Acitretin—Isotretinoin—RXRA—prostate cancer	0.00103	0.176	CrCbGaD
Acitretin—RARA—testis—prostate cancer	0.00102	0.0284	CbGeAlD
Acitretin—RARB—lymph node—prostate cancer	0.000967	0.0268	CbGeAlD
Acitretin—Alitretinoin—RXRA—prostate cancer	0.000842	0.143	CrCbGaD
Acitretin—RARG—lymph node—prostate cancer	0.000789	0.0219	CbGeAlD
Acitretin—RARA—lymph node—prostate cancer	0.000742	0.0206	CbGeAlD
Acitretin—Tretinoin—RXRA—prostate cancer	0.000593	0.101	CrCbGaD
Acitretin—ALB—testis—prostate cancer	0.000577	0.016	CbGeAlD
Acitretin—ALB—lymph node—prostate cancer	0.000418	0.0116	CbGeAlD
Acitretin—Tretinoin—CYP2C18—prostate cancer	0.000304	0.0517	CrCbGaD
Acitretin—Tretinoin—CYP3A5—prostate cancer	0.0002	0.0341	CrCbGaD
Acitretin—Tretinoin—CYP2A6—prostate cancer	0.000194	0.033	CrCbGaD
Acitretin—Vitamin A—CYP1A1—prostate cancer	0.00014	0.0239	CrCbGaD
Acitretin—Tretinoin—CYP1A1—prostate cancer	0.000136	0.0231	CrCbGaD
Acitretin—Tretinoin—CYP3A4—prostate cancer	8.66e-05	0.0147	CrCbGaD
Acitretin—Vision blurred—Prednisone—prostate cancer	3.58e-05	0.000184	CcSEcCtD
Acitretin—Infection—Docetaxel—prostate cancer	3.58e-05	0.000183	CcSEcCtD
Acitretin—Weight decreased—Doxorubicin—prostate cancer	3.57e-05	0.000183	CcSEcCtD
Acitretin—Sinusitis—Epirubicin—prostate cancer	3.57e-05	0.000183	CcSEcCtD
Acitretin—Feeling abnormal—Etoposide—prostate cancer	3.57e-05	0.000183	CcSEcCtD
Acitretin—Diarrhoea—Mitoxantrone—prostate cancer	3.56e-05	0.000183	CcSEcCtD
Acitretin—Dry mouth—Capecitabine—prostate cancer	3.55e-05	0.000182	CcSEcCtD
Acitretin—Vomiting—Estradiol—prostate cancer	3.55e-05	0.000182	CcSEcCtD
Acitretin—Gastrointestinal pain—Etoposide—prostate cancer	3.54e-05	0.000182	CcSEcCtD
Acitretin—Ill-defined disorder—Prednisone—prostate cancer	3.53e-05	0.000181	CcSEcCtD
Acitretin—Rash—Estradiol—prostate cancer	3.52e-05	0.000181	CcSEcCtD
Acitretin—Dermatitis—Estradiol—prostate cancer	3.52e-05	0.000181	CcSEcCtD
Acitretin—Headache—Estradiol—prostate cancer	3.5e-05	0.00018	CcSEcCtD
Acitretin—Skin disorder—Docetaxel—prostate cancer	3.5e-05	0.000179	CcSEcCtD
Acitretin—Oedema—Capecitabine—prostate cancer	3.48e-05	0.000179	CcSEcCtD
Acitretin—Angioedema—Prednisone—prostate cancer	3.47e-05	0.000178	CcSEcCtD
Acitretin—Infection—Capecitabine—prostate cancer	3.46e-05	0.000178	CcSEcCtD
Acitretin—Neuropathy peripheral—Doxorubicin—prostate cancer	3.45e-05	0.000177	CcSEcCtD
Acitretin—Urticaria—Etoposide—prostate cancer	3.44e-05	0.000177	CcSEcCtD
Acitretin—Haemoglobin—Epirubicin—prostate cancer	3.43e-05	0.000176	CcSEcCtD
Acitretin—Stomatitis—Doxorubicin—prostate cancer	3.43e-05	0.000176	CcSEcCtD
Acitretin—Jaundice—Doxorubicin—prostate cancer	3.43e-05	0.000176	CcSEcCtD
Acitretin—Anorexia—Docetaxel—prostate cancer	3.43e-05	0.000176	CcSEcCtD
Acitretin—Malaise—Prednisone—prostate cancer	3.43e-05	0.000176	CcSEcCtD
Acitretin—Rhinitis—Epirubicin—prostate cancer	3.43e-05	0.000176	CcSEcCtD
Acitretin—Body temperature increased—Etoposide—prostate cancer	3.42e-05	0.000176	CcSEcCtD
Acitretin—Abdominal pain—Etoposide—prostate cancer	3.42e-05	0.000176	CcSEcCtD
Acitretin—Conjunctivitis—Doxorubicin—prostate cancer	3.42e-05	0.000176	CcSEcCtD
Acitretin—Urinary tract infection—Doxorubicin—prostate cancer	3.42e-05	0.000176	CcSEcCtD
Acitretin—Hepatitis—Epirubicin—prostate cancer	3.42e-05	0.000175	CcSEcCtD
Acitretin—Haemorrhage—Epirubicin—prostate cancer	3.42e-05	0.000175	CcSEcCtD
Acitretin—Hypoaesthesia—Epirubicin—prostate cancer	3.4e-05	0.000174	CcSEcCtD
Acitretin—Pharyngitis—Epirubicin—prostate cancer	3.39e-05	0.000174	CcSEcCtD
Acitretin—Skin disorder—Capecitabine—prostate cancer	3.38e-05	0.000174	CcSEcCtD
Acitretin—Hyperhidrosis—Capecitabine—prostate cancer	3.37e-05	0.000173	CcSEcCtD
Acitretin—Oedema peripheral—Epirubicin—prostate cancer	3.37e-05	0.000173	CcSEcCtD
Acitretin—Haematuria—Doxorubicin—prostate cancer	3.36e-05	0.000172	CcSEcCtD
Acitretin—Epistaxis—Doxorubicin—prostate cancer	3.32e-05	0.00017	CcSEcCtD
Acitretin—Anorexia—Capecitabine—prostate cancer	3.32e-05	0.00017	CcSEcCtD
Acitretin—Nausea—Estradiol—prostate cancer	3.32e-05	0.00017	CcSEcCtD
Acitretin—Vomiting—Mitoxantrone—prostate cancer	3.31e-05	0.00017	CcSEcCtD
Acitretin—Sinusitis—Doxorubicin—prostate cancer	3.3e-05	0.00017	CcSEcCtD
Acitretin—Visual impairment—Epirubicin—prostate cancer	3.29e-05	0.000169	CcSEcCtD
Acitretin—Rash—Mitoxantrone—prostate cancer	3.28e-05	0.000168	CcSEcCtD
Acitretin—Dermatitis—Mitoxantrone—prostate cancer	3.28e-05	0.000168	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.28e-05	0.000168	CcSEcCtD
Acitretin—Headache—Mitoxantrone—prostate cancer	3.26e-05	0.000167	CcSEcCtD
Acitretin—Insomnia—Docetaxel—prostate cancer	3.25e-05	0.000167	CcSEcCtD
Acitretin—Arthralgia—Prednisone—prostate cancer	3.24e-05	0.000166	CcSEcCtD
Acitretin—Myalgia—Prednisone—prostate cancer	3.24e-05	0.000166	CcSEcCtD
Acitretin—Paraesthesia—Docetaxel—prostate cancer	3.23e-05	0.000166	CcSEcCtD
Acitretin—Anxiety—Prednisone—prostate cancer	3.23e-05	0.000166	CcSEcCtD
Acitretin—Somnolence—Docetaxel—prostate cancer	3.2e-05	0.000164	CcSEcCtD
Acitretin—Discomfort—Prednisone—prostate cancer	3.2e-05	0.000164	CcSEcCtD
Acitretin—Eye disorder—Epirubicin—prostate cancer	3.19e-05	0.000164	CcSEcCtD
Acitretin—Hypersensitivity—Etoposide—prostate cancer	3.19e-05	0.000164	CcSEcCtD
Acitretin—Tinnitus—Epirubicin—prostate cancer	3.19e-05	0.000163	CcSEcCtD
Acitretin—Haemoglobin—Doxorubicin—prostate cancer	3.18e-05	0.000163	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.17e-05	0.000163	CcSEcCtD
Acitretin—Flushing—Epirubicin—prostate cancer	3.17e-05	0.000163	CcSEcCtD
Acitretin—Rhinitis—Doxorubicin—prostate cancer	3.17e-05	0.000163	CcSEcCtD
Acitretin—Dyspepsia—Docetaxel—prostate cancer	3.17e-05	0.000163	CcSEcCtD
Acitretin—Hepatitis—Doxorubicin—prostate cancer	3.16e-05	0.000162	CcSEcCtD
Acitretin—Haemorrhage—Doxorubicin—prostate cancer	3.16e-05	0.000162	CcSEcCtD
Acitretin—Insomnia—Capecitabine—prostate cancer	3.15e-05	0.000162	CcSEcCtD
Acitretin—Hypoaesthesia—Doxorubicin—prostate cancer	3.15e-05	0.000161	CcSEcCtD
Acitretin—Pharyngitis—Doxorubicin—prostate cancer	3.14e-05	0.000161	CcSEcCtD
Acitretin—Paraesthesia—Capecitabine—prostate cancer	3.13e-05	0.000161	CcSEcCtD
Acitretin—Decreased appetite—Docetaxel—prostate cancer	3.13e-05	0.000161	CcSEcCtD
Acitretin—Oedema peripheral—Doxorubicin—prostate cancer	3.11e-05	0.00016	CcSEcCtD
Acitretin—Gastrointestinal disorder—Docetaxel—prostate cancer	3.11e-05	0.000159	CcSEcCtD
Acitretin—Asthenia—Etoposide—prostate cancer	3.11e-05	0.000159	CcSEcCtD
Acitretin—Oedema—Prednisone—prostate cancer	3.1e-05	0.000159	CcSEcCtD
Acitretin—Fatigue—Docetaxel—prostate cancer	3.1e-05	0.000159	CcSEcCtD
Acitretin—Angiopathy—Epirubicin—prostate cancer	3.1e-05	0.000159	CcSEcCtD
Acitretin—Nausea—Mitoxantrone—prostate cancer	3.09e-05	0.000159	CcSEcCtD
Acitretin—Immune system disorder—Epirubicin—prostate cancer	3.09e-05	0.000158	CcSEcCtD
Acitretin—Infection—Prednisone—prostate cancer	3.08e-05	0.000158	CcSEcCtD
Acitretin—Pain—Docetaxel—prostate cancer	3.08e-05	0.000158	CcSEcCtD
Acitretin—Constipation—Docetaxel—prostate cancer	3.08e-05	0.000158	CcSEcCtD
Acitretin—Dyspepsia—Capecitabine—prostate cancer	3.07e-05	0.000157	CcSEcCtD
Acitretin—Chills—Epirubicin—prostate cancer	3.07e-05	0.000157	CcSEcCtD
Acitretin—Pruritus—Etoposide—prostate cancer	3.06e-05	0.000157	CcSEcCtD
Acitretin—Visual impairment—Doxorubicin—prostate cancer	3.05e-05	0.000156	CcSEcCtD
Acitretin—Decreased appetite—Capecitabine—prostate cancer	3.03e-05	0.000155	CcSEcCtD
Acitretin—Alopecia—Epirubicin—prostate cancer	3.02e-05	0.000155	CcSEcCtD
Acitretin—Skin disorder—Prednisone—prostate cancer	3.01e-05	0.000155	CcSEcCtD
Acitretin—Gastrointestinal disorder—Capecitabine—prostate cancer	3.01e-05	0.000154	CcSEcCtD
Acitretin—Fatigue—Capecitabine—prostate cancer	3e-05	0.000154	CcSEcCtD
Acitretin—Hyperhidrosis—Prednisone—prostate cancer	3e-05	0.000154	CcSEcCtD
Acitretin—Constipation—Capecitabine—prostate cancer	2.98e-05	0.000153	CcSEcCtD
Acitretin—Pain—Capecitabine—prostate cancer	2.98e-05	0.000153	CcSEcCtD
Acitretin—Erythema—Epirubicin—prostate cancer	2.97e-05	0.000153	CcSEcCtD
Acitretin—Feeling abnormal—Docetaxel—prostate cancer	2.97e-05	0.000152	CcSEcCtD
Acitretin—Diarrhoea—Etoposide—prostate cancer	2.96e-05	0.000152	CcSEcCtD
Acitretin—Anorexia—Prednisone—prostate cancer	2.96e-05	0.000152	CcSEcCtD
Acitretin—Eye disorder—Doxorubicin—prostate cancer	2.95e-05	0.000152	CcSEcCtD
Acitretin—Tinnitus—Doxorubicin—prostate cancer	2.95e-05	0.000151	CcSEcCtD
Acitretin—Gastrointestinal pain—Docetaxel—prostate cancer	2.94e-05	0.000151	CcSEcCtD
Acitretin—Flushing—Doxorubicin—prostate cancer	2.93e-05	0.000151	CcSEcCtD
Acitretin—Tension—Epirubicin—prostate cancer	2.92e-05	0.00015	CcSEcCtD
Acitretin—Dysgeusia—Epirubicin—prostate cancer	2.91e-05	0.000149	CcSEcCtD
Acitretin—Nervousness—Epirubicin—prostate cancer	2.89e-05	0.000148	CcSEcCtD
Acitretin—Back pain—Epirubicin—prostate cancer	2.88e-05	0.000148	CcSEcCtD
Acitretin—Feeling abnormal—Capecitabine—prostate cancer	2.87e-05	0.000147	CcSEcCtD
Acitretin—Angiopathy—Doxorubicin—prostate cancer	2.87e-05	0.000147	CcSEcCtD
Acitretin—Dizziness—Etoposide—prostate cancer	2.86e-05	0.000147	CcSEcCtD
Acitretin—Muscle spasms—Epirubicin—prostate cancer	2.86e-05	0.000147	CcSEcCtD
Acitretin—Immune system disorder—Doxorubicin—prostate cancer	2.86e-05	0.000147	CcSEcCtD
Acitretin—Gastrointestinal pain—Capecitabine—prostate cancer	2.85e-05	0.000146	CcSEcCtD
Acitretin—Abdominal pain—Docetaxel—prostate cancer	2.84e-05	0.000146	CcSEcCtD
Acitretin—Body temperature increased—Docetaxel—prostate cancer	2.84e-05	0.000146	CcSEcCtD
Acitretin—Chills—Doxorubicin—prostate cancer	2.84e-05	0.000146	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Prednisone—prostate cancer	2.83e-05	0.000145	CcSEcCtD
Acitretin—Insomnia—Prednisone—prostate cancer	2.81e-05	0.000144	CcSEcCtD
Acitretin—Vision blurred—Epirubicin—prostate cancer	2.8e-05	0.000144	CcSEcCtD
Acitretin—Alopecia—Doxorubicin—prostate cancer	2.79e-05	0.000143	CcSEcCtD
Acitretin—Paraesthesia—Prednisone—prostate cancer	2.79e-05	0.000143	CcSEcCtD
Acitretin—Urticaria—Capecitabine—prostate cancer	2.77e-05	0.000142	CcSEcCtD
Acitretin—Ill-defined disorder—Epirubicin—prostate cancer	2.76e-05	0.000142	CcSEcCtD
Acitretin—Abdominal pain—Capecitabine—prostate cancer	2.75e-05	0.000141	CcSEcCtD
Acitretin—Body temperature increased—Capecitabine—prostate cancer	2.75e-05	0.000141	CcSEcCtD
Acitretin—Vomiting—Etoposide—prostate cancer	2.75e-05	0.000141	CcSEcCtD
Acitretin—Erythema—Doxorubicin—prostate cancer	2.75e-05	0.000141	CcSEcCtD
Acitretin—Dyspepsia—Prednisone—prostate cancer	2.73e-05	0.00014	CcSEcCtD
Acitretin—Rash—Etoposide—prostate cancer	2.73e-05	0.00014	CcSEcCtD
Acitretin—Dermatitis—Etoposide—prostate cancer	2.73e-05	0.00014	CcSEcCtD
Acitretin—Headache—Etoposide—prostate cancer	2.71e-05	0.000139	CcSEcCtD
Acitretin—Tension—Doxorubicin—prostate cancer	2.7e-05	0.000139	CcSEcCtD
Acitretin—Decreased appetite—Prednisone—prostate cancer	2.7e-05	0.000138	CcSEcCtD
Acitretin—Dysgeusia—Doxorubicin—prostate cancer	2.69e-05	0.000138	CcSEcCtD
Acitretin—Malaise—Epirubicin—prostate cancer	2.68e-05	0.000138	CcSEcCtD
Acitretin—Fatigue—Prednisone—prostate cancer	2.68e-05	0.000137	CcSEcCtD
Acitretin—Nervousness—Doxorubicin—prostate cancer	2.67e-05	0.000137	CcSEcCtD
Acitretin—Back pain—Doxorubicin—prostate cancer	2.66e-05	0.000137	CcSEcCtD
Acitretin—Constipation—Prednisone—prostate cancer	2.65e-05	0.000136	CcSEcCtD
Acitretin—Hypersensitivity—Docetaxel—prostate cancer	2.65e-05	0.000136	CcSEcCtD
Acitretin—Muscle spasms—Doxorubicin—prostate cancer	2.65e-05	0.000136	CcSEcCtD
Acitretin—Cough—Epirubicin—prostate cancer	2.6e-05	0.000133	CcSEcCtD
Acitretin—Vision blurred—Doxorubicin—prostate cancer	2.59e-05	0.000133	CcSEcCtD
Acitretin—Asthenia—Docetaxel—prostate cancer	2.58e-05	0.000132	CcSEcCtD
Acitretin—Nausea—Etoposide—prostate cancer	2.57e-05	0.000132	CcSEcCtD
Acitretin—Hypersensitivity—Capecitabine—prostate cancer	2.57e-05	0.000132	CcSEcCtD
Acitretin—Feeling abnormal—Prednisone—prostate cancer	2.56e-05	0.000131	CcSEcCtD
Acitretin—Ill-defined disorder—Doxorubicin—prostate cancer	2.55e-05	0.000131	CcSEcCtD
Acitretin—Pruritus—Docetaxel—prostate cancer	2.55e-05	0.000131	CcSEcCtD
Acitretin—Gastrointestinal pain—Prednisone—prostate cancer	2.54e-05	0.00013	CcSEcCtD
Acitretin—Chest pain—Epirubicin—prostate cancer	2.53e-05	0.00013	CcSEcCtD
Acitretin—Arthralgia—Epirubicin—prostate cancer	2.53e-05	0.00013	CcSEcCtD
Acitretin—Myalgia—Epirubicin—prostate cancer	2.53e-05	0.00013	CcSEcCtD
Acitretin—Anxiety—Epirubicin—prostate cancer	2.52e-05	0.000129	CcSEcCtD
Acitretin—Discomfort—Epirubicin—prostate cancer	2.5e-05	0.000128	CcSEcCtD
Acitretin—Asthenia—Capecitabine—prostate cancer	2.5e-05	0.000128	CcSEcCtD
Acitretin—Malaise—Doxorubicin—prostate cancer	2.48e-05	0.000127	CcSEcCtD
Acitretin—Dry mouth—Epirubicin—prostate cancer	2.48e-05	0.000127	CcSEcCtD
Acitretin—Urticaria—Prednisone—prostate cancer	2.47e-05	0.000127	CcSEcCtD
Acitretin—Pruritus—Capecitabine—prostate cancer	2.47e-05	0.000126	CcSEcCtD
Acitretin—Diarrhoea—Docetaxel—prostate cancer	2.46e-05	0.000126	CcSEcCtD
Acitretin—Abdominal pain—Prednisone—prostate cancer	2.45e-05	0.000126	CcSEcCtD
Acitretin—Body temperature increased—Prednisone—prostate cancer	2.45e-05	0.000126	CcSEcCtD
Acitretin—Oedema—Epirubicin—prostate cancer	2.43e-05	0.000125	CcSEcCtD
Acitretin—Infection—Epirubicin—prostate cancer	2.41e-05	0.000124	CcSEcCtD
Acitretin—Cough—Doxorubicin—prostate cancer	2.4e-05	0.000123	CcSEcCtD
Acitretin—Diarrhoea—Capecitabine—prostate cancer	2.38e-05	0.000122	CcSEcCtD
Acitretin—Dizziness—Docetaxel—prostate cancer	2.38e-05	0.000122	CcSEcCtD
Acitretin—Skin disorder—Epirubicin—prostate cancer	2.36e-05	0.000121	CcSEcCtD
Acitretin—Hyperhidrosis—Epirubicin—prostate cancer	2.35e-05	0.00012	CcSEcCtD
Acitretin—Chest pain—Doxorubicin—prostate cancer	2.34e-05	0.00012	CcSEcCtD
Acitretin—Arthralgia—Doxorubicin—prostate cancer	2.34e-05	0.00012	CcSEcCtD
Acitretin—Myalgia—Doxorubicin—prostate cancer	2.34e-05	0.00012	CcSEcCtD
Acitretin—Anxiety—Doxorubicin—prostate cancer	2.33e-05	0.00012	CcSEcCtD
Acitretin—Discomfort—Doxorubicin—prostate cancer	2.31e-05	0.000119	CcSEcCtD
Acitretin—Anorexia—Epirubicin—prostate cancer	2.31e-05	0.000119	CcSEcCtD
Acitretin—Dizziness—Capecitabine—prostate cancer	2.3e-05	0.000118	CcSEcCtD
Acitretin—Dry mouth—Doxorubicin—prostate cancer	2.29e-05	0.000118	CcSEcCtD
Acitretin—Vomiting—Docetaxel—prostate cancer	2.29e-05	0.000117	CcSEcCtD
Acitretin—Hypersensitivity—Prednisone—prostate cancer	2.29e-05	0.000117	CcSEcCtD
Acitretin—Rash—Docetaxel—prostate cancer	2.27e-05	0.000116	CcSEcCtD
Acitretin—Dermatitis—Docetaxel—prostate cancer	2.27e-05	0.000116	CcSEcCtD
Acitretin—Headache—Docetaxel—prostate cancer	2.25e-05	0.000116	CcSEcCtD
Acitretin—Oedema—Doxorubicin—prostate cancer	2.25e-05	0.000115	CcSEcCtD
Acitretin—Infection—Doxorubicin—prostate cancer	2.23e-05	0.000114	CcSEcCtD
Acitretin—Asthenia—Prednisone—prostate cancer	2.23e-05	0.000114	CcSEcCtD
Acitretin—Vomiting—Capecitabine—prostate cancer	2.22e-05	0.000114	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.21e-05	0.000113	CcSEcCtD
Acitretin—Rash—Capecitabine—prostate cancer	2.2e-05	0.000113	CcSEcCtD
Acitretin—Pruritus—Prednisone—prostate cancer	2.2e-05	0.000113	CcSEcCtD
Acitretin—Insomnia—Epirubicin—prostate cancer	2.2e-05	0.000113	CcSEcCtD
Acitretin—Dermatitis—Capecitabine—prostate cancer	2.19e-05	0.000113	CcSEcCtD
Acitretin—Headache—Capecitabine—prostate cancer	2.18e-05	0.000112	CcSEcCtD
Acitretin—Skin disorder—Doxorubicin—prostate cancer	2.18e-05	0.000112	CcSEcCtD
Acitretin—Paraesthesia—Epirubicin—prostate cancer	2.18e-05	0.000112	CcSEcCtD
Acitretin—Hyperhidrosis—Doxorubicin—prostate cancer	2.17e-05	0.000111	CcSEcCtD
Acitretin—Somnolence—Epirubicin—prostate cancer	2.16e-05	0.000111	CcSEcCtD
Acitretin—Anorexia—Doxorubicin—prostate cancer	2.14e-05	0.00011	CcSEcCtD
Acitretin—Nausea—Docetaxel—prostate cancer	2.14e-05	0.00011	CcSEcCtD
Acitretin—Dyspepsia—Epirubicin—prostate cancer	2.14e-05	0.00011	CcSEcCtD
Acitretin—Diarrhoea—Prednisone—prostate cancer	2.12e-05	0.000109	CcSEcCtD
Acitretin—Decreased appetite—Epirubicin—prostate cancer	2.11e-05	0.000108	CcSEcCtD
Acitretin—Gastrointestinal disorder—Epirubicin—prostate cancer	2.1e-05	0.000108	CcSEcCtD
Acitretin—Fatigue—Epirubicin—prostate cancer	2.09e-05	0.000107	CcSEcCtD
Acitretin—Constipation—Epirubicin—prostate cancer	2.08e-05	0.000107	CcSEcCtD
Acitretin—Pain—Epirubicin—prostate cancer	2.08e-05	0.000107	CcSEcCtD
Acitretin—Nausea—Capecitabine—prostate cancer	2.07e-05	0.000106	CcSEcCtD
Acitretin—Dizziness—Prednisone—prostate cancer	2.05e-05	0.000105	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.05e-05	0.000105	CcSEcCtD
Acitretin—Insomnia—Doxorubicin—prostate cancer	2.03e-05	0.000104	CcSEcCtD
Acitretin—Paraesthesia—Doxorubicin—prostate cancer	2.02e-05	0.000103	CcSEcCtD
Acitretin—Feeling abnormal—Epirubicin—prostate cancer	2e-05	0.000103	CcSEcCtD
Acitretin—Somnolence—Doxorubicin—prostate cancer	2e-05	0.000102	CcSEcCtD
Acitretin—Gastrointestinal pain—Epirubicin—prostate cancer	1.98e-05	0.000102	CcSEcCtD
Acitretin—Dyspepsia—Doxorubicin—prostate cancer	1.98e-05	0.000101	CcSEcCtD
Acitretin—Vomiting—Prednisone—prostate cancer	1.97e-05	0.000101	CcSEcCtD
Acitretin—Rash—Prednisone—prostate cancer	1.96e-05	0.0001	CcSEcCtD
Acitretin—Dermatitis—Prednisone—prostate cancer	1.96e-05	0.0001	CcSEcCtD
Acitretin—Decreased appetite—Doxorubicin—prostate cancer	1.95e-05	0.0001	CcSEcCtD
Acitretin—Headache—Prednisone—prostate cancer	1.94e-05	9.98e-05	CcSEcCtD
Acitretin—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.94e-05	9.95e-05	CcSEcCtD
Acitretin—Fatigue—Doxorubicin—prostate cancer	1.94e-05	9.94e-05	CcSEcCtD
Acitretin—Urticaria—Epirubicin—prostate cancer	1.93e-05	9.89e-05	CcSEcCtD
Acitretin—Constipation—Doxorubicin—prostate cancer	1.92e-05	9.86e-05	CcSEcCtD
Acitretin—Pain—Doxorubicin—prostate cancer	1.92e-05	9.86e-05	CcSEcCtD
Acitretin—Abdominal pain—Epirubicin—prostate cancer	1.92e-05	9.85e-05	CcSEcCtD
Acitretin—Body temperature increased—Epirubicin—prostate cancer	1.92e-05	9.85e-05	CcSEcCtD
Acitretin—Feeling abnormal—Doxorubicin—prostate cancer	1.85e-05	9.5e-05	CcSEcCtD
Acitretin—Nausea—Prednisone—prostate cancer	1.84e-05	9.46e-05	CcSEcCtD
Acitretin—Gastrointestinal pain—Doxorubicin—prostate cancer	1.84e-05	9.42e-05	CcSEcCtD
Acitretin—Hypersensitivity—Epirubicin—prostate cancer	1.79e-05	9.18e-05	CcSEcCtD
Acitretin—Urticaria—Doxorubicin—prostate cancer	1.78e-05	9.16e-05	CcSEcCtD
Acitretin—Body temperature increased—Doxorubicin—prostate cancer	1.78e-05	9.11e-05	CcSEcCtD
Acitretin—Abdominal pain—Doxorubicin—prostate cancer	1.78e-05	9.11e-05	CcSEcCtD
Acitretin—Asthenia—Epirubicin—prostate cancer	1.74e-05	8.94e-05	CcSEcCtD
Acitretin—Pruritus—Epirubicin—prostate cancer	1.72e-05	8.81e-05	CcSEcCtD
Acitretin—Diarrhoea—Epirubicin—prostate cancer	1.66e-05	8.52e-05	CcSEcCtD
Acitretin—Hypersensitivity—Doxorubicin—prostate cancer	1.65e-05	8.49e-05	CcSEcCtD
Acitretin—Asthenia—Doxorubicin—prostate cancer	1.61e-05	8.27e-05	CcSEcCtD
Acitretin—Dizziness—Epirubicin—prostate cancer	1.61e-05	8.24e-05	CcSEcCtD
Acitretin—Pruritus—Doxorubicin—prostate cancer	1.59e-05	8.15e-05	CcSEcCtD
Acitretin—Vomiting—Epirubicin—prostate cancer	1.54e-05	7.92e-05	CcSEcCtD
Acitretin—Diarrhoea—Doxorubicin—prostate cancer	1.54e-05	7.89e-05	CcSEcCtD
Acitretin—Rash—Epirubicin—prostate cancer	1.53e-05	7.85e-05	CcSEcCtD
Acitretin—Dermatitis—Epirubicin—prostate cancer	1.53e-05	7.85e-05	CcSEcCtD
Acitretin—Headache—Epirubicin—prostate cancer	1.52e-05	7.8e-05	CcSEcCtD
Acitretin—Dizziness—Doxorubicin—prostate cancer	1.49e-05	7.62e-05	CcSEcCtD
Acitretin—Nausea—Epirubicin—prostate cancer	1.44e-05	7.4e-05	CcSEcCtD
Acitretin—Vomiting—Doxorubicin—prostate cancer	1.43e-05	7.33e-05	CcSEcCtD
Acitretin—Rash—Doxorubicin—prostate cancer	1.42e-05	7.27e-05	CcSEcCtD
Acitretin—Dermatitis—Doxorubicin—prostate cancer	1.41e-05	7.26e-05	CcSEcCtD
Acitretin—Headache—Doxorubicin—prostate cancer	1.41e-05	7.22e-05	CcSEcCtD
Acitretin—Nausea—Doxorubicin—prostate cancer	1.33e-05	6.85e-05	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	6.62e-06	3.95e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	6.61e-06	3.94e-05	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTGS2—prostate cancer	6.6e-06	3.93e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CXCL8—prostate cancer	6.56e-06	3.91e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—AKR1C3—prostate cancer	6.56e-06	3.91e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—JAK2—prostate cancer	6.54e-06	3.9e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PRKACB—prostate cancer	6.52e-06	3.89e-05	CbGpPWpGaD
Acitretin—RBP1—Disease—KRAS—prostate cancer	6.47e-06	3.86e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP17A1—prostate cancer	6.46e-06	3.85e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—IGF1—prostate cancer	6.45e-06	3.84e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CDKN1B—prostate cancer	6.41e-06	3.82e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—AR—prostate cancer	6.39e-06	3.81e-05	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.39e-06	3.81e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	6.37e-06	3.8e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—PRKACB—prostate cancer	6.35e-06	3.79e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	6.3e-06	3.76e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—ERBB2—prostate cancer	6.3e-06	3.76e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CASP3—prostate cancer	6.28e-06	3.74e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL2—prostate cancer	6.27e-06	3.74e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—B4GALT4—prostate cancer	6.23e-06	3.71e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—HPGD—prostate cancer	6.23e-06	3.71e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CD—prostate cancer	6.19e-06	3.69e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—NCOA2—prostate cancer	6.15e-06	3.67e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—SERPINE1—prostate cancer	6.12e-06	3.65e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CCND1—prostate cancer	6.11e-06	3.65e-05	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—IL6—prostate cancer	6.08e-06	3.63e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CTNNB1—prostate cancer	6.05e-06	3.61e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—NCOA2—prostate cancer	5.99e-06	3.57e-05	CbGpPWpGaD
Acitretin—RBP1—Disease—PIK3CA—prostate cancer	5.94e-06	3.54e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MMP9—prostate cancer	5.93e-06	3.54e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CDKN1A—prostate cancer	5.91e-06	3.53e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PTEN—prostate cancer	5.9e-06	3.52e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PRKCQ—prostate cancer	5.88e-06	3.51e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—SLC5A5—prostate cancer	5.87e-06	3.5e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—TNFRSF21—prostate cancer	5.85e-06	3.49e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—SIRT1—prostate cancer	5.83e-06	3.48e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PLAUR—prostate cancer	5.81e-06	3.47e-05	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTEN—prostate cancer	5.75e-06	3.43e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—VDR—prostate cancer	5.74e-06	3.42e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP2E1—prostate cancer	5.73e-06	3.42e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC5A5—prostate cancer	5.71e-06	3.41e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—MTAP—prostate cancer	5.69e-06	3.4e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP7B1—prostate cancer	5.69e-06	3.4e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—JAK2—prostate cancer	5.68e-06	3.39e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—NQO1—prostate cancer	5.67e-06	3.38e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—EP300—prostate cancer	5.63e-06	3.36e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—TH—prostate cancer	5.59e-06	3.33e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	5.57e-06	3.32e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.55e-06	3.31e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SULT1E1—prostate cancer	5.55e-06	3.31e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SRD5A1—prostate cancer	5.55e-06	3.31e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP3A4—prostate cancer	5.53e-06	3.3e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—CTNNB1—prostate cancer	5.51e-06	3.29e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.5e-06	3.28e-05	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—EP300—prostate cancer	5.49e-06	3.27e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SRC—prostate cancer	5.47e-06	3.26e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP1B1—prostate cancer	5.43e-06	3.24e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MMP9—prostate cancer	5.4e-06	3.22e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—VAV3—prostate cancer	5.39e-06	3.22e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CB—prostate cancer	5.39e-06	3.22e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	5.39e-06	3.21e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—VEGFA—prostate cancer	5.33e-06	3.18e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	5.31e-06	3.17e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ACSL4—prostate cancer	5.29e-06	3.16e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—HSD17B3—prostate cancer	5.29e-06	3.16e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—STAT3—prostate cancer	5.28e-06	3.15e-05	CbGpPWpGaD
Acitretin—RBP1—Disease—IL6—prostate cancer	5.26e-06	3.14e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GGT1—prostate cancer	5.26e-06	3.14e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—ERCC2—prostate cancer	5.25e-06	3.13e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—ITPR1—prostate cancer	5.23e-06	3.12e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	5.23e-06	3.12e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—NCOA1—prostate cancer	5.18e-06	3.09e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—NR3C1—prostate cancer	5.17e-06	3.08e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—EP300—prostate cancer	5.12e-06	3.05e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP19A1—prostate cancer	5.11e-06	3.05e-05	CbGpPWpGaD
Acitretin—RARG—Gene Expression—MYC—prostate cancer	5.09e-06	3.04e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PHGDH—prostate cancer	5.08e-06	3.03e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ARG2—prostate cancer	5.08e-06	3.03e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—UMPS—prostate cancer	5.08e-06	3.03e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	5.05e-06	3.01e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—NCOA1—prostate cancer	5.05e-06	3.01e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—SRC—prostate cancer	4.98e-06	2.97e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—LDHB—prostate cancer	4.98e-06	2.97e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—IL2—prostate cancer	4.95e-06	2.95e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MYC—prostate cancer	4.9e-06	2.92e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TGFB1—prostate cancer	4.89e-06	2.92e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP3A5—prostate cancer	4.89e-06	2.91e-05	CbGpPWpGaD
Acitretin—RBP1—Disease—AKT1—prostate cancer	4.86e-06	2.9e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—VEGFA—prostate cancer	4.85e-06	2.89e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—PPARA—prostate cancer	4.84e-06	2.89e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—STAT3—prostate cancer	4.8e-06	2.86e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—RXRA—prostate cancer	4.8e-06	2.86e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.8e-06	2.86e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—EGFR—prostate cancer	4.8e-06	2.86e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—COMT—prostate cancer	4.75e-06	2.83e-05	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—MYC—prostate cancer	4.74e-06	2.83e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTP1—prostate cancer	4.73e-06	2.82e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PDHA1—prostate cancer	4.72e-06	2.81e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—TCN2—prostate cancer	4.72e-06	2.81e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTA3—prostate cancer	4.72e-06	2.81e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—UCP3—prostate cancer	4.72e-06	2.81e-05	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MYC—prostate cancer	4.66e-06	2.78e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ITPR1—prostate cancer	4.65e-06	2.77e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—ITGB3—prostate cancer	4.63e-06	2.76e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.57e-06	2.73e-05	CbGpPWpGaD
Acitretin—RARB—Gene Expression—MYC—prostate cancer	4.57e-06	2.72e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KRAS—prostate cancer	4.53e-06	2.7e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—HSD3B1—prostate cancer	4.5e-06	2.68e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC22A3—prostate cancer	4.5e-06	2.68e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—TGFB1—prostate cancer	4.45e-06	2.65e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—TYMS—prostate cancer	4.39e-06	2.62e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—ESR1—prostate cancer	4.39e-06	2.62e-05	CbGpPWpGaD
Acitretin—RARA—Gene Expression—MYC—prostate cancer	4.38e-06	2.61e-05	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MYC—prostate cancer	4.38e-06	2.61e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—LPL—prostate cancer	4.37e-06	2.6e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—EGFR—prostate cancer	4.36e-06	2.6e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTM1—prostate cancer	4.34e-06	2.59e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—SRC—prostate cancer	4.32e-06	2.58e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—TBXAS1—prostate cancer	4.32e-06	2.57e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTA4—prostate cancer	4.32e-06	2.57e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—LPL—prostate cancer	4.26e-06	2.54e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	4.22e-06	2.52e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—VEGFA—prostate cancer	4.21e-06	2.51e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTA2—prostate cancer	4.21e-06	2.51e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CA—prostate cancer	4.16e-06	2.48e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ABCG5—prostate cancer	4.15e-06	2.48e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SULT1A1—prostate cancer	4.15e-06	2.48e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—KRAS—prostate cancer	4.12e-06	2.46e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP1A1—prostate cancer	4.12e-06	2.46e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ERCC2—prostate cancer	4.08e-06	2.44e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PLAU—prostate cancer	4.08e-06	2.43e-05	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CA—prostate cancer	4.06e-06	2.42e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTA1—prostate cancer	4.06e-06	2.42e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TP53—prostate cancer	4.03e-06	2.4e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTO1—prostate cancer	4.01e-06	2.39e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—HSD3B2—prostate cancer	4.01e-06	2.39e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—NAT2—prostate cancer	4.01e-06	2.39e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—CAV1—prostate cancer	3.98e-06	2.38e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	3.86e-06	2.3e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	3.86e-06	2.3e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP2C18—prostate cancer	3.85e-06	2.29e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—LRP2—prostate cancer	3.85e-06	2.29e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PLCB2—prostate cancer	3.85e-06	2.29e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—CREBBP—prostate cancer	3.85e-06	2.29e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—MTHFR—prostate cancer	3.84e-06	2.29e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—P4HB—prostate cancer	3.77e-06	2.25e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PPARA—prostate cancer	3.77e-06	2.25e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL6—prostate cancer	3.69e-06	2.2e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC22A1—prostate cancer	3.67e-06	2.19e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—PPARA—prostate cancer	3.67e-06	2.19e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CG—prostate cancer	3.63e-06	2.16e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.63e-06	2.16e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—SERPINE1—prostate cancer	3.61e-06	2.15e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—EGF—prostate cancer	3.59e-06	2.14e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SULT2A1—prostate cancer	3.58e-06	2.13e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CAV1—prostate cancer	3.54e-06	2.11e-05	CbGpPWpGaD
Acitretin—RARG—Gene Expression—AKT1—prostate cancer	3.53e-06	2.11e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—MED12—prostate cancer	3.52e-06	2.1e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GNG5—prostate cancer	3.49e-06	2.08e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—AKT1—prostate cancer	3.4e-06	2.03e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.38e-06	2.02e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—CREBBP—prostate cancer	3.36e-06	2.01e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—NCOA3—prostate cancer	3.36e-06	2e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—IL6—prostate cancer	3.35e-06	2e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IGF1—prostate cancer	3.32e-06	1.98e-05	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—AKT1—prostate cancer	3.31e-06	1.98e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.3e-06	1.97e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	3.29e-06	1.96e-05	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—AKT1—prostate cancer	3.23e-06	1.93e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CG—prostate cancer	3.23e-06	1.92e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—HPGDS—prostate cancer	3.21e-06	1.91e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CD—prostate cancer	3.19e-06	1.9e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP2C19—prostate cancer	3.19e-06	1.9e-05	CbGpPWpGaD
Acitretin—RARB—Gene Expression—AKT1—prostate cancer	3.17e-06	1.89e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—SERPINE1—prostate cancer	3.16e-06	1.88e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTT1—prostate cancer	3.11e-06	1.86e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ACHE—prostate cancer	3.11e-06	1.86e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—AKT1—prostate cancer	3.09e-06	1.85e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP2A6—prostate cancer	3.07e-06	1.83e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.06e-06	1.83e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—INS—prostate cancer	3.05e-06	1.82e-05	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—AKT1—prostate cancer	3.04e-06	1.81e-05	CbGpPWpGaD
Acitretin—RARA—Gene Expression—AKT1—prostate cancer	3.04e-06	1.81e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—NOS3—prostate cancer	3.01e-06	1.8e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—AKR1C3—prostate cancer	2.99e-06	1.78e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CREBBP—prostate cancer	2.99e-06	1.78e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PRKACB—prostate cancer	2.98e-06	1.77e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP17A1—prostate cancer	2.94e-06	1.76e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—JAK2—prostate cancer	2.93e-06	1.75e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.91e-06	1.74e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.9e-06	1.73e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CD—prostate cancer	2.84e-06	1.69e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—NCOA2—prostate cancer	2.81e-06	1.67e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CB—prostate cancer	2.78e-06	1.66e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	2.69e-06	1.6e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—NOS3—prostate cancer	2.68e-06	1.6e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC5A5—prostate cancer	2.68e-06	1.6e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP2E1—prostate cancer	2.61e-06	1.56e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—NQO1—prostate cancer	2.59e-06	1.54e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IL2—prostate cancer	2.55e-06	1.52e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—TH—prostate cancer	2.55e-06	1.52e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.53e-06	1.51e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP3A4—prostate cancer	2.52e-06	1.5e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.51e-06	1.5e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP1B1—prostate cancer	2.48e-06	1.48e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CB—prostate cancer	2.47e-06	1.47e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTGS2—prostate cancer	2.45e-06	1.46e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GGT1—prostate cancer	2.4e-06	1.43e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—NCOA1—prostate cancer	2.36e-06	1.41e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP19A1—prostate cancer	2.33e-06	1.39e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—EP300—prostate cancer	2.29e-06	1.37e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MYC—prostate cancer	2.28e-06	1.36e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—RXRA—prostate cancer	2.25e-06	1.34e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—SRC—prostate cancer	2.23e-06	1.33e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.19e-06	1.3e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—VEGFA—prostate cancer	2.17e-06	1.29e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—COMT—prostate cancer	2.17e-06	1.29e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTP1—prostate cancer	2.16e-06	1.29e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTEN—prostate cancer	2.14e-06	1.27e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ITPR1—prostate cancer	2.12e-06	1.27e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.09e-06	1.24e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—EP300—prostate cancer	2.04e-06	1.21e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—TYMS—prostate cancer	2e-06	1.2e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TGFB1—prostate cancer	1.99e-06	1.19e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTM1—prostate cancer	1.98e-06	1.18e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—LPL—prostate cancer	1.94e-06	1.16e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP1A1—prostate cancer	1.88e-06	1.12e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ERCC2—prostate cancer	1.86e-06	1.11e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—KRAS—prostate cancer	1.84e-06	1.1e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—MTHFR—prostate cancer	1.75e-06	1.04e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PPARA—prostate cancer	1.72e-06	1.02e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CA—prostate cancer	1.7e-06	1.01e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TP53—prostate cancer	1.64e-06	9.78e-06	CbGpPWpGaD
Acitretin—ALB—Metabolism—CAV1—prostate cancer	1.62e-06	9.63e-06	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—AKT1—prostate cancer	1.58e-06	9.44e-06	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.54e-06	9.2e-06	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CA—prostate cancer	1.51e-06	8.99e-06	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CG—prostate cancer	1.47e-06	8.77e-06	CbGpPWpGaD
Acitretin—ALB—Metabolism—INS—prostate cancer	1.39e-06	8.31e-06	CbGpPWpGaD
Acitretin—ALB—Hemostasis—AKT1—prostate cancer	1.38e-06	8.26e-06	CbGpPWpGaD
Acitretin—ALB—Metabolism—CREBBP—prostate cancer	1.36e-06	8.13e-06	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CD—prostate cancer	1.29e-06	7.71e-06	CbGpPWpGaD
Acitretin—RXRA—Metabolism—AKT1—prostate cancer	1.23e-06	7.34e-06	CbGpPWpGaD
Acitretin—ALB—Metabolism—NOS3—prostate cancer	1.22e-06	7.28e-06	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CB—prostate cancer	1.13e-06	6.72e-06	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTGS2—prostate cancer	1.12e-06	6.66e-06	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTEN—prostate cancer	9.74e-07	5.81e-06	CbGpPWpGaD
Acitretin—ALB—Metabolism—EP300—prostate cancer	9.29e-07	5.54e-06	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CA—prostate cancer	6.87e-07	4.1e-06	CbGpPWpGaD
Acitretin—ALB—Metabolism—AKT1—prostate cancer	5.61e-07	3.35e-06	CbGpPWpGaD
